|
Research and Markets: Roche's Quilizumab (Asthma) – Forecast and Market …
Business Wire (press release) IgE is important in the development of allergic asthma, as it binds to mast cells and basophils, which play a significant role in the pathogenesis of asthma. IgE ultimately triggers the release of histamines, prostaglandins, and leukotrienes, which … Research and Markets: Cinquil (Reslizumab) Asthma Treatment – Forecast and … Research and Markets: Roche's Lebrikizumab (Asthma) Treatment – Forecast … |
View full post on asthma – Google News